Total Funding
93
81
Total FundingVenture - Series Unknown raised
Growth Score
26 pts
Heat Score
28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
12874
PlaqueTec develops device to monitor and understand the biological processes associated with heart disease.
- Annalisa Jenkins: Chief Executive OfficerPast Role: Dimension Therapeutics, CEO
About the Company
PlaqueTec is pioneering the development of biomarker-based strategies to transform the prevention, diagnosis, and treatment of Coronary Artery Disease, the leading cause of death worldwide.
As with any successful startup, PlaqueTec has a strong leadership team with a unified vision for continued growth, and a commitment to changing the current
standard of care in the diagnosis, prevention, and treatment of CAD. They work closely with cardiologists, academic scientists, and biopharmaceutical companies around the world to advance understanding of CAD and the inflammatory processes underlying the progression of this common and dangerous disease, and to accelerate the testing of existing and new therapeutic agents for CAD.
